Combination chemotherapy with paclitaxel plus carboplatin versus paclitaxel plus gemcitabine in inoperable non-small cell lung cancer: A phase III randomized study. Preliminary results

Seminars in Oncology

Volumn 27, Issue 1 SUPPL. 1, 2000, Pages 3-8

  Kosmidis, P ^a   Mylonakis, N ^a   Dimopoulos, A ^a   Pavlidis, N ^a   Fountzilas, G ^a   Samantas, E ^a   Dimitriadis, K ^a   Kalophonos, C ^a   Tsavdaridis, D ^a   Skarlos, D ^a  

^a NONE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; GEMCITABINE; PACLITAXEL;

AREA UNDER THE CURVE; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CARDIOTOXICITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER TOXICITY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NEUROTOXICITY; NEUTROPENIA; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARBOPLATIN; CARCINOMA, NON-SMALL-CELL LUNG; DEOXYCYTIDINE; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PACLITAXEL; SURVIVAL ANALYSIS;

EID: 0033963483     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)